Bone Marrow Microvessel Density (MVD) in Adult Acute Myeloid Leukemia (AML): Therapy Induced Changes and Effects on Survival

Reference

• Fiedler, W., Graeven, U., Ergiin, S., Verago, S., Kilic, N., Stockschläder, M., et al. (1997) "Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia", Blood, 89, 1870— 1875.
   PubMed Web of Science ®Google Scholar
• Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., et al. (1999) "Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia", Blood, 94, 3717 — 3721.
   Google Scholar
• De Bont, E.S.J.M., Rosati, S., Jacobs, S., Kamps, W.A. and Vellenga, E. (2001) "Increased bone marrow vascularisation in patients with acute myeloid leukemia: a possible role for vascular endothelial growth factor", Br. J. Haematol., 113, 296— 304.
   Web of Science ®Google Scholar
• Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., et al. (2000) "In acute and chronic leukemias and myelodysplastic syndromes", Blood, 96, 2240–2245.
   Google Scholar
• Pedro, T., Ruiz, S., Beiker, R., Burger, H., Steins, M., Kienast, J., et al. (2000) "Increased in the bone morrow of patients with acute myeloid leukemia", Blood, 95, 2637–2644.
   Google Scholar
• Turley, H., Scott, P.A.E., Watts, V.M., Bicknell, R., Harris, A.L. and Gatter, K.C. (1998) "Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1", J. Pathol., 186, 313— 318.
   PubMed Web of Science ®Google Scholar
• Perez-Atayde, AR., Sallan, SE., Tedrow, U., Connors, S., Allred, E. and Folkman, J. (1997) "Spectrum of tumor in the bone morrow of the children with acute lymphoblastic leukemia", Am. J. Pathol., 150, 815–821.
   Web of Science ®Google Scholar
• Rajkumar, S.V., Fonseca, R., Witzig, T.E., Gertz, M.A. and Greipp, P.R. (1999) "Bone morrow in patients achieving complete response after stem cell transplantation for multiple myeloma", Leukemia, 13, 469–472.
   Google Scholar
• Ribatti, D., Vacca, A., Nico, B., Quondamatteo, F., Ria, R., Minischetti, M., et al. (1999) "Bone marrow and mast cell density increase simultaneously with progression of human multiple myeloma", Br. J. Cancer, 79, 451 —455.
   Web of Science ®Google Scholar
• Vacca, A., Ribalti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., et al. (1999) "Bone marrow neovascularisation, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma", Blood, 93, 3064 —3073.
   Google Scholar
• Lundberg, L.G., Lerner, R., Sundelin, P., Rogers, R., Folkman, J. and Palmblad, J. (2000) "Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity", Am. J. Pathol., 157, 15–19.
   Web of Science ®Google Scholar
• Gupta, D., Treon, S.P., Shima, Y., et al. ( 2001) "Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applica-tions", Leukemia, 15, 1950— 1961.
   PubMed Web of Science ®Google Scholar
• Hideshima, T., Chauhan, D., Podar, K., Schlossman, R.L., Richardson, P. and Anderson, K.C. (2001) "Novel therapies targeting the myeloma cell and its bone marrow microenviron-ment", Semin. °ma, 28, 607–612.
   Google Scholar
• Shami, P.J., Hussong, J.W. and Rogers, G.M. (1998) "Evidence of increased in the bone morrow of the patients with acute nonlymphoblastic leukemia. Abstract 2105", Blood, 92(Supp.1): 512a.
   Google Scholar
• Di Raimondo, F., Palumbo, G.A., Azzaro, M.P. and Giustolisi, R. (2000) "In acute myeloid leukemia", Blood, 96, 3656.
   Google Scholar
• Hussong, J.W., Rogers, G.M. and Shami, P.J. (2000) "Evidence of incerased in patients with acute myeloid leukemia", Blood, 95, 309 — 313.
   Google Scholar
• Reddy, V. and Moreb, J. (2000) "Prognostic correlation of increased in acute myeloid leukemia with cytogenetics", Blood, 96, 1617.
   Google Scholar
• Cuneo, A., Van Orshoven, A., Michaux, J.L., Boogaerts, M., Louwagie, A., Doyen, C., et al. (1990) "Morphologic, immunologic and cytogenetic studies in erythroleukemia: evidence for multi-lineage involvement and identification two distinct cytogenetic-clinicopathological types", Br. J. Haematol., 75, 346— 354.
   Web of Science ®Google Scholar
• Stasi, R., Del Poeta, G., Venditti, A., Masi, M., Stipa, E., Dentamaro, T., et al. (1994) "Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0)", Blood, 83, 1619–1625.
   Google Scholar
• Venditti, A., Del Poeta, G., Buccisano, F., Tamburini, A., Cox, MC., Stasi, R., et al. (1997) "Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes", Blood, 89, 621–629.
   Google Scholar
• Sezer, 0., Niemoller, K., Jakob, C., Zavrski, I., Heider, U., Eucker, J., Kaufmann, 0., et al. (2001) "Relationship between bone marrow and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma", Ann. Hematol., 80(10), 598 — 601.
   PubMed Web of Science ®Google Scholar
• Keck, P.J., Hauser, S.D., Krivi, G., Sanzo, K., Warren, T., Feder, J., et al. (1989) "Vascular permeability factor, an endothelial cell mitogen related to platelet derived growth factor", Science, 246, 309— 1312.
   Google Scholar
• Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V. and Ferrara, N. (1989) "Vascular endothelial growth factor is a secreted angiogenic mitogen", Science, 246, 1306— 1309.
   Google Scholar
• Conn, G., Bayne, M., Soderman, L., Kwok, P.W., Sullivan, K.A., Plisi, TM., et al. (1990) "Amino acid and DNA sequence of vascular endothelial cell mitogen homologus to platelet-derived growth factor", Proc. Natl. Acad. Sci. USA, 87, 2628 — 2632.
   PubMed Web of Science ®Google Scholar
• Dvorak, H.F., Brown, L.F., Detmar, M. and Dvorak, A.M. (1995) "Vascular permeability factor/vascular endothelial growth factor, microvascular hiperpermeability and", Am. J. Pathol., 146, 1029 — 1039.
   Web of Science ®Google Scholar
• Ferrara, N. (1997) The role of vascular endothelial growth factor in the regulation of blood vessel growth. In Tumor, edited by Bicknell, R., Lewis, CE., Ferrara, N. Pp 185–199. UK: Oxford University Press.
   Google Scholar
• Nicosia, R.F. (1998) "What is the role of vascular endothelial growth factor related molecules in tumor?", Am. J. Pathol., 153, 11 — 16.
   Web of Science ®Google Scholar
• Ratajczak, M.Z., Ratajczak, J., Machalinski, B., Majka, M. and Marlitcz, V. (1998) "Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulation of haematopoietic cell growth", Br. J. Haematol., 103, 969–979.
   Web of Science ®Google Scholar
• Bellamy, W., Richter, L., Fruttiger, Y. and Grogan, T. (1999) "Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies", Cancer Res., 59, 728–733.
   PubMed Web of Science ®Google Scholar
• Pelletier, L., Regnard, J. and Fellmann, D. (2000) "Charbord, P. An in vitro model for the study of human bone marrow: role of hematopoietic cytokines", Lab. Invest., 80, 501 —511.
   Google Scholar
• Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, Si. and Holash, J. (2000) "Vascular- specific growth factors and Blood vessel formation", Nature, 407, 242–248.
   Google Scholar
• Smolich, B.D., Yuen, HA., West, K.A., Giles, F.J., Albitar, M. and Cherrington, J.M. (2001) "The antiangiogenic protein kinase inhibitors 5U5416 and 5U6668 inhibit the SCF receptor (c-kit) in human myeloid leukemia cell line and acute myeloid leukemia blasts", Blood, 97, 1413 — 1421.
   Google Scholar
• List, A.F. (2001) Targeting in hematological malignancies. In ASH 2001, Education Book. Pp 447–452.
   Google Scholar